Colin Dayan

University of Birmingham — United Kingdom

Biochemistry, Genetics and Molecular Biology · Life Sciences

72h-index20.4kcitations540works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Diabetes and associated disorders(145), Diabetes Management and Research(121), Thyroid Disorders and Treatments(117), Pancreatic function and diabetes(85), Thyroid Cancer Diagnosis and Treatment(52)

Publications529 total

Horizon scanning from panel discussions at the EUGOGO Global TED Forum 2025 London
Eye·2026Open Access
Tracking GAD-specific T-cell expansions in Type 1 diabetes by intradermal GAD-Alum challenge
2025Open Access
Baseline insulin secretion determines the response to abatacept in Stage 1 type 1 diabetes
2025Open Access
Baseline insulin secretion determines the response to abatacept in Stage 1 type 1 diabetes
2025Open Access
Baseline Insulin Secretion Determines Response to Abatacept in Stage 1 Type 1 Diabetes
Diabetes·2025Open Access
Role of Autoantibody Testing in TED and Graves Diagnosis and Management
2025Open Access
A novel capillary-adjusted home oral glucose tolerance test: a practical and reliable alternative to the gold standard venous method in childhood early-stage type 1 diabetes
Endocrine Abstracts·2025
Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy
Diabetes/Metabolism Research and Reviews·2025Open Access
System Failure in Type 1 Diabetes: What Stakeholders Need to Know to Expedite Therapeutic Options
Diabetes Spectrum·2025Open Access
Potential cost-effectiveness of childhood screening for type 1 diabetes: Examining reducing Diabetic Ketoacidosis at diagnosis and long-term outcomes to assess the justifiable cost per child screened.
NIHR Open Research·2025Open Access
Automated Oral Minimal Models for Rapid Estimation of Insulin Sensitivity and Beta-Cell Responsivity in Large-Scale Data Sets: A Validation Study
Journal of Diabetes Science and Technology·2025Open Access
<b>A Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval</b>
2025Open Access
<b>A Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval</b>
2025Open Access
Novel Approach for Assessing Outcomes of Type 1 Diabetes Prevention Trials Over a Fixed Time Interval
Diabetes·2025Open Access
Evaluation of Thyroid Hormone Status: Are Simultaneous TSH and FT4 Tests Necessary? Analysis of Thyroid Function Test Results Taken From the Greater Manchester Care Record 2010–2023
Clinical Endocrinology·2025Open Access
Author response for "Autoimmune Type 1 Diabetes in the Era of Disease‐Modifying Immune Therapy"
2025
Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis
The Journal of Clinical Endocrinology & Metabolism·2025· 3 citedOpen Access
The Role of microRNAs as Biomarkers of Pancreas Transplant Rejection; EMPAR Study
American Journal of Transplantation·2025· 1 cited
Beta Cell Specific Cell Free DNA and Trypsinogen for the Diagnosis of Rejection in Pancreas Transplantation The EMPAR Study
American Journal of Transplantation·2025· 1 citedOpen Access
1962-LB: Baseline Insulin Secretion Determines the Response to Abatacept In Stage 1 Type 1 Diabetes
Diabetes·2025
page 1 of 27Next →

Frequent Co-authors

Peter Taylor(11), Mark Peakman(10), Vijay Panicker(8), Onyebuchi Okosieme(7), Bijay Vaidya(7), Timothy Tree(7), John H. Lazarus(6), George J. Kahaly(5), Simon H. S. Pearce(5), Ponnusamy Saravanan(5), Sefina Arif(5), Ania Skowera(4), Petros Perros(4), Jake Powrie(4), Luigi Bartalena(3), Anja Eckstein(3), Michele Marinò(3), Wilmar M. Wiersinga(3), Göksün Ayvaz(3), Onur Konuk(3)